Bill Spohn

3.9k total citations · 3 hit papers
20 papers, 3.2k citations indexed

About

Bill Spohn is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Bill Spohn has authored 20 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Bill Spohn's work include RNA Interference and Gene Delivery (4 papers), interferon and immune responses (3 papers) and Virus-based gene therapy research (3 papers). Bill Spohn is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), interferon and immune responses (3 papers) and Virus-based gene therapy research (3 papers). Bill Spohn collaborates with scholars based in United States, Germany and Taiwan. Bill Spohn's co-authors include Mien‐Chie Hung, Weiya Xia, Binhua P. Zhou, Yong Liao, Yong Wen, Mong‐Hong Lee, Yiyu Zou, Shiaw‐Yih Lin, Ka Yin Kwong and Richard G. Pestell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Cell Biology.

In The Last Decade

Bill Spohn

19 papers receiving 3.1k citations

Hit Papers

Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced p... 2000 2026 2008 2017 2001 2001 2000 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bill Spohn United States 13 2.4k 1.3k 485 416 385 20 3.2k
Yong Wen United States 16 1.9k 0.8× 1.0k 0.8× 481 1.0× 519 1.2× 344 0.9× 23 2.9k
Toshiyuki Sakamaki United States 19 2.1k 0.9× 1.0k 0.8× 712 1.5× 315 0.8× 300 0.8× 25 2.9k
Hugh Arnold United States 15 2.0k 0.8× 797 0.6× 398 0.8× 412 1.0× 210 0.5× 18 2.7k
Mickey C.‐T. Hu United States 33 3.2k 1.3× 1.3k 1.0× 923 1.9× 543 1.3× 391 1.0× 51 4.4k
Shawn Brisbay United States 23 1.7k 0.7× 907 0.7× 465 1.0× 599 1.4× 203 0.5× 35 2.5k
Rui‐An Wang United States 29 2.2k 0.9× 1.1k 0.9× 604 1.2× 201 0.5× 720 1.9× 56 3.1k
Giacomo Manenti Italy 30 1.8k 0.8× 811 0.6× 590 1.2× 388 0.9× 663 1.7× 102 3.0k
Eileen Friedman United States 36 2.1k 0.9× 1.1k 0.9× 358 0.7× 150 0.4× 283 0.7× 75 3.2k
Frances Kittrell United States 32 1.9k 0.8× 1.8k 1.4× 735 1.5× 208 0.5× 678 1.8× 61 3.3k
François X. Claret United States 30 1.9k 0.8× 1.0k 0.8× 599 1.2× 232 0.6× 251 0.7× 52 2.8k

Countries citing papers authored by Bill Spohn

Since Specialization
Citations

This map shows the geographic impact of Bill Spohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bill Spohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bill Spohn more than expected).

Fields of papers citing papers by Bill Spohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bill Spohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bill Spohn. The network helps show where Bill Spohn may publish in the future.

Co-authorship network of co-authors of Bill Spohn

This figure shows the co-authorship network connecting the top 25 collaborators of Bill Spohn. A scholar is included among the top collaborators of Bill Spohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bill Spohn. Bill Spohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauer, H., et al.. (2015). Altered Whole Blood Chemiluminescence during Hemodialysis Using Different Dialysis Membranes. Contributions to nephrology. 37. 89–95.
2.
Nakagawa‐Goto, Kyoko, Koji Yamada, Seikou Nakamura, et al.. (2007). Antitumor agents. 258. Syntheses and evaluation of dietary antioxidant—taxoid conjugates as novel cytotoxic agents. Bioorganic & Medicinal Chemistry Letters. 17(18). 5204–5209. 42 indexed citations
3.
Xie, Xiaoming, Weiya Xia, Zhongkui Li, et al.. (2007). Targeted Expression of BikDD Eradicates Pancreatic Tumors in Noninvasive Imaging Models. Cancer Cell. 12(1). 52–65. 61 indexed citations
4.
Bisanz, Kristen, Jie Yu, Magnus Edlund, et al.. (2005). Targeting ECM–Integrin Interaction with Liposome-Encapsulated Small Interfering RNAs Inhibits the Growth of Human Prostate Cancer in a Bone Xenograft Imaging Model. Molecular Therapy. 12(4). 634–643. 70 indexed citations
5.
Shao, Ruping, Dung‐Fang Lee, Yong Wen, et al.. (2005). E1A Sensitizes Cancer Cells to TRAIL-Induced Apoptosis through Enhancement of Caspase Activation. Molecular Cancer Research. 3(4). 219–226. 18 indexed citations
6.
Spohn, Bill, et al.. (2004). Delivery of DNA to Tumor Cells Using Cationic Liposomes. Humana Press eBooks. 245. 125–136. 4 indexed citations
7.
Wen, Yong, Li Su, Weiya Xia, et al.. (2004). A delayed chemically induced tumorigenesis in Brca2 mutant mice. Oncogene. 23(10). 1896–1901. 10 indexed citations
8.
Wen, Yong, Dipak Kumar Giri, Duen‐Hwa Yan, et al.. (2003). Prostate‐specific antitumor activity by probasin promoter‐directed p202 expression. Molecular Carcinogenesis. 37(3). 130–137. 12 indexed citations
9.
Ding, Yi, Yong Wen, Bill Spohn, et al.. (2002). Proapoptotic and antitumor activities of adenovirus-mediated p202 gene transfer.. PubMed. 8(10). 3290–7. 9 indexed citations
10.
Zhou, Binhua P., Yong Liao, Weiya Xia, et al.. (2001). Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nature Cell Biology. 3(3). 245–252. 915 indexed citations breakdown →
11.
Zhou, Binhua P., Yong Liao, Weiya Xia, et al.. (2001). HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nature Cell Biology. 3(11). 973–982. 749 indexed citations breakdown →
12.
Wen, Yong, Duen‐Hwa Yan, Bailiang Wang, et al.. (2001). p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft models.. PubMed. 61(19). 7142–7. 32 indexed citations
13.
Wen, Yong, et al.. (2000). Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cells.. PubMed. 60(1). 42–6. 36 indexed citations
14.
Wen, Yong, Mickey C.‐T. Hu, Keishi Makino, et al.. (2000). HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway.. PubMed. 60(24). 6841–5. 364 indexed citations
15.
Lin, Shiaw‐Yih, Weiya Xia, Ka Yin Kwong, et al.. (2000). β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression. Proceedings of the National Academy of Sciences. 97(8). 4262–4266. 672 indexed citations breakdown →
16.
17.
Shao, Ruping, Mickey C.‐T. Hu, Binhua P. Zhou, et al.. (1999). E1A Sensitizes Cells to Tumor Necrosis Factor-induced Apoptosis through Inhibition of IκB Kinases and Nuclear Factor κB Activities. Journal of Biological Chemistry. 274(31). 21495–21498. 84 indexed citations
18.
Spohn, Bill, et al.. (1983). Comparison of urine cytology versus fine needle aspiration cytology in monitoring renal allograft dysfunction.. PubMed. 19. 495–9. 3 indexed citations
19.
Sprenger, K., et al.. (1983). Improvement of uremic neuropathy and hypogeusia by dialysate zinc supplementation: a double-blind study.. PubMed. 16. S315–8. 48 indexed citations
20.
Sprenger, K., et al.. (1979). Hemodiafiltration Using Readily Available Equipment. PubMed. 3(1). 27–39. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026